Unione Europea - italiano - EMA (European Medicines Agency)

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vaccini - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

Unione Europea - italiano - EMA (European Medicines Agency)

novartis europharm limited - erenumab - emicrania - analgesici - aimovig è indicato per la profilassi dell'emicrania negli adulti che hanno almeno 4 emicrania giorni al mese quando iniziare il trattamento con aimovig.

Unione Europea - italiano - EMA (European Medicines Agency)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccini - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Unione Europea - italiano - EMA (European Medicines Agency)

janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - vaccini - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. l'uso di questo vaccino dovrebbe essere in conformità con le raccomandazioni ufficiali.

Unione Europea - italiano - EMA (European Medicines Agency)

astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - vaccini - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. l'uso di questo vaccino dovrebbe essere in conformità con le raccomandazioni ufficiali.

Italia - italiano - Ministero della Salute

bio 98 s.r.l - povidone iodio - povidone iodio - 10000 mg - povidone-iodine

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - mycobacterium bovis aquos d6 - gocce per via orale, di strofinare - mycobacterium bovis aquos d6 dilutio. - gemäss homöopathischem arzneimittelbild bei akuter asthenie mit hypotonie - farmaci omeopatici

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - mycobacterium bovis d5 - capsule - la triturazione d5 330 mg mycobacterium bovis, con kapselrol: ipromellosa, eccipienti pro capsula. - gemäss homöopathischem arzneimittelbild bei akuter asthenie mit hypotonie - farmaci omeopatici

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

norgine ag - macrogolum 3350, natrii chloridum, natrii hydrogenocarbonas, kalii chloridum - polvere - macrogolum 3350 13.125 g, natrii chloridum 350.7 mg, natrii hydrogenocarbonas 178.5 mg, kalii chloridum 46.6 mg, acesulfamum kalicum, aromatica limone und zitrone, citralum, e 220, ad pulverem pro charta corresp. natrium 186.81 mg. - stitichezza, koprostase - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - erenumabum - soluzione iniettabile in siringa preriempita - erenumabum 70 mg, saccharum, polysorbatum 80, acidum aceticum glaciale, natrii hydroxidum, natrium 0.2 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - migräneprophylaxe - biotechnologika